Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient.

C TaibiM TempestilliAntonio D'AvolioA R GarbugliaA De NicolòM MontalbanoG D'Offizi

Published in: Journal of clinical pharmacy and therapeutics (2017)

This case report can provide information useful for clinical practice in this set of patients and can open new perspectives in evaluating actual SOF/LDV bioavailability.

Keyphrases

case report
hepatitis c virus
end stage renal disease
clinical practice
prognostic factors
ejection fraction
newly diagnosed
chronic kidney disease
minimally invasive
human immunodeficiency virus